These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
3. Diagnosis, prognosis and treatment of patients with gastrointestinal stromal tumour (GIST) and germline mutation of KIT exon 13. Bachet JB; Landi B; Laurent-Puig P; Italiano A; Le Cesne A; Lévy P; Safar V; Duffaud F; Blay JY; Emile JF Eur J Cancer; 2013 Jul; 49(11):2531-41. PubMed ID: 23648119 [TBL] [Abstract][Full Text] [Related]
4. KIT immunohistochemistry and mutation status in gastrointestinal stromal tumours (GISTs) evaluated for treatment with imatinib. Loughrey MB; Trivett M; Beshay V; Dobrovic A; Kovalenko S; Murray W; Lade S; Turner H; McArthur GA; Zalcberg J; Waring PM Histopathology; 2006 Jul; 49(1):52-65. PubMed ID: 16842246 [TBL] [Abstract][Full Text] [Related]
5. Familial gastrointestinal stromal tumor with germ line mutation of the juxtamembrane domain of the KIT gene observed in relatively young women. Kuroda N; Tanida N; Hirota S; Daum O; Hes O; Michal M; Lee GH Ann Diagn Pathol; 2011 Oct; 15(5):358-61. PubMed ID: 20952281 [TBL] [Abstract][Full Text] [Related]
6. Analysis of KIT mutations in sporadic and familial gastrointestinal stromal tumors: therapeutic implications through protein modeling. Tarn C; Merkel E; Canutescu AA; Shen W; Skorobogatko Y; Heslin MJ; Eisenberg B; Birbe R; Patchefsky A; Dunbrack R; Arnoletti JP; von Mehren M; Godwin AK Clin Cancer Res; 2005 May; 11(10):3668-77. PubMed ID: 15897563 [TBL] [Abstract][Full Text] [Related]
7. Imatinib efficacy by tumor genotype in Korean patients with advanced gastrointestinal stromal tumors (GIST): The Korean GIST Study Group (KGSG) study. Kang HJ; Ryu MH; Kim KM; Park YS; Choi J; Ryoo BY; Kim WH; Im SA; Bang YJ; Park SH; Lee JH; Chung IJ; Bae HI; Kim JG; Lee KH; Song HS; Kwon HC; Baek JH; Shin DB; Lee KE; Kang YK Acta Oncol; 2012 Apr; 51(4):528-36. PubMed ID: 22150077 [TBL] [Abstract][Full Text] [Related]
8. Multiple gastrointestinal stromal tumors with a germline c-kit mutation. Kim HJ; Lim SJ; Park K; Yuh YJ; Jang SJ; Choi J Pathol Int; 2005 Oct; 55(10):655-9. PubMed ID: 16185297 [TBL] [Abstract][Full Text] [Related]
9. Pathological response of gastrointestinal stromal tumour to imatinib treatment correlates with tumour KIT mutational status in individual tumour clones. Loughrey MB; Beshay V; Dobrovic A; Zalcberg J; Waring PM Histopathology; 2006 Jul; 49(1):99-100. PubMed ID: 16842259 [No Abstract] [Full Text] [Related]
10. A sporadic multiple gastrointestinal stromal tumor with unique clinical and molecular features. Pera M; Iglesias M; Puig S; Martínez-Avilés L; Bellosillo B Hum Pathol; 2011 Aug; 42(8):1194-9. PubMed ID: 21295327 [TBL] [Abstract][Full Text] [Related]
11. Patient with high-risk GIST not associated with c-KIT mutations: same benefit from adjuvant therapy? Izquierdo ME; Bonastre MT Anticancer Drugs; 2012 Jun; 23 Suppl():S7-9. PubMed ID: 22739668 [TBL] [Abstract][Full Text] [Related]
12. [GIST refractory to imatinib treatment]. Onozawa Y; Terashima M Gan To Kagaku Ryoho; 2011 May; 38(5):738-43. PubMed ID: 21566433 [TBL] [Abstract][Full Text] [Related]
13. Familial gastrointestinal stromal tumors caused by the novel KIT exon 17 germline mutation N822Y. Thalheimer A; Schlemmer M; Bueter M; Merkelbach-Bruse S; Schildhaus HU; Buettner R; Hartung E; Thiede A; Meyer D; Fein M; Maroske J; Wardelmann E Am J Surg Pathol; 2008 Oct; 32(10):1560-5. PubMed ID: 18724244 [TBL] [Abstract][Full Text] [Related]
14. Surgical management in metastatic gastrointestinal stromal tumor (GIST) patients after imatinib mesylate treatment. Yeh CN; Chen TW; Tseng JH; Liu YY; Wang SY; Tsai CY; Chiang KC; Hwang TL; Jan YY; Chen MF J Surg Oncol; 2010 Nov; 102(6):599-603. PubMed ID: 20976730 [TBL] [Abstract][Full Text] [Related]
15. Acquired resistance to imatinib in gastrointestinal stromal tumours caused by multiple KIT mutations. Wardelmann E; Thomas N; Merkelbach-Bruse S; Pauls K; Speidel N; Büttner R; Bihl H; Leutner CC; Heinicke T; Hohenberger P Lancet Oncol; 2005 Apr; 6(4):249-51. PubMed ID: 15811621 [No Abstract] [Full Text] [Related]
16. Multiple gastrointestinal stromal tumors: Clinicopathologic and genetic analysis of 12 patients. Kang DY; Park CK; Choi JS; Jin SY; Kim HJ; Joo M; Kang MS; Moon WS; Yun KJ; Yu ES; Kang H; Kim KM Am J Surg Pathol; 2007 Feb; 31(2):224-32. PubMed ID: 17255767 [TBL] [Abstract][Full Text] [Related]
17. Kinase mutations and imatinib mesylate response for 64 Taiwanese with advanced GIST: preliminary experience from Chang Gung Memorial Hospital. Yeh CN; Chen TW; Lee HL; Liu YY; Chao TC; Hwang TL; Jan YY; Chen MF Ann Surg Oncol; 2007 Mar; 14(3):1123-8. PubMed ID: 17195905 [TBL] [Abstract][Full Text] [Related]
18. [Gastrointestinal stromal tumors (GIST) - clinical experience and current therapeutical aspects]. Iarŭmov N; Velev G; Todorov G; Lukanova Ts; Angelov K; Gribnev P; Sokolov M; Toshev S Khirurgiia (Sofiia); 2007; (4):27-32. PubMed ID: 18443532 [TBL] [Abstract][Full Text] [Related]
19. Inherited predisposition to gastrointestinal stromal tumor. Agarwal R; Robson M Hematol Oncol Clin North Am; 2009 Feb; 23(1):1-13, vii. PubMed ID: 19248967 [TBL] [Abstract][Full Text] [Related]
20. Analysis of mutation and expression of c-kit and PDGFR-alpha gene in gastrointestinal stromal tumor. Zheng S; Chen LR; Wang HJ; Chen SZ Hepatogastroenterology; 2007 Dec; 54(80):2285-90. PubMed ID: 18265649 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]